The hunt for medicines to treat rare diseases and a flurry of mining deals are again providing respite to the slump in mergers and acquisitions.
To read the entire story, you must be logged in.
Please log in now or register with us.
Intelligence for the Dealmaking Community since 1965
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
